226 related articles for article (PubMed ID: 24618302)
1. Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors.
Zhou G; Ting PC; Wishart G; Zorn N; Aslanian RG; Lin M; Smith M; Walker SS; Cook J; Van Heek M; Lachowicz J
Bioorg Med Chem Lett; 2014 Apr; 24(7):1790-4. PubMed ID: 24618302
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of cyclohexane carboxylic acid head group containing isoxazole and thiazole analogs as DGAT1 inhibitors.
Kandre S; Bhagat PR; Reddy MM; Dalal R; Dixit A; Deshmukh NJ; Anthony J; Bose J; Anupindi R; Sharma R; Gupte A
Eur J Med Chem; 2014 May; 79():203-15. PubMed ID: 24735646
[TBL] [Abstract][Full Text] [Related]
3. Discovery and optimization of adamantane carboxylic acid derivatives as potent diacylglycerol acyltransferase 1 inhibitors for the potential treatment of obesity and diabetes.
Pagire SH; Pagire HS; Lee GB; Han SJ; Kwak HJ; Kim JY; Kim KY; Rhee SD; Ryu JI; Song JS; Bae MA; Park MJ; Kim D; Lee DH; Ahn JH
Eur J Med Chem; 2015 Aug; 101():716-35. PubMed ID: 26218650
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of potent carboxylic acid DGAT1 inhibitors with high cell permeability.
Bali U; Barba O; Dawson G; Gattrell WT; Horswill JG; Pan DA; Procter MJ; Rasamison CM; Sambrook Smith CP; Taylor-Warne A; Wong-Kai-In P
Bioorg Med Chem Lett; 2012 Jan; 22(2):824-8. PubMed ID: 22217874
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
Kadam KS; Jadhav RD; Kandre S; Guha T; Reddy MM; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Srinivasan S; Devle J; Damre A; Nemmani KV; Gupte A; Sharma R
Eur J Med Chem; 2013 Jul; 65():337-47. PubMed ID: 23735282
[TBL] [Abstract][Full Text] [Related]
6. Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors.
DeVita RJ; Pinto S
J Med Chem; 2013 Dec; 56(24):9820-5. PubMed ID: 23919406
[TBL] [Abstract][Full Text] [Related]
7. Lead optimization of a pyridine-carboxamide series as DGAT-1 inhibitors.
Ting PC; Lee JF; Zorn N; Kim HM; Aslanian RG; Lin M; Smith M; Walker SS; Cook J; Van Heek M; Lachowicz J
Bioorg Med Chem Lett; 2013 Feb; 23(4):985-8. PubMed ID: 23317570
[TBL] [Abstract][Full Text] [Related]
8. Thiadiazoles as new inhibitors of diacylglycerol acyltransferase type 1.
Mougenot P; Namane C; Fett E; Camy F; Dadji-Faïhun R; Langot G; Monseau C; Onofri B; Pacquet F; Pascal C; Crespin O; Ben-Hassine M; Ragot JL; Van-Pham T; Philippo C; Chatelain-Egger F; Péron P; Le Bail JC; Guillot E; Chamiot-Clerc P; Chabanaud MA; Pruniaux MP; Schmidt F; Venier O; Nicolaï E; Viviani F
Bioorg Med Chem Lett; 2012 Apr; 22(7):2497-502. PubMed ID: 22405833
[TBL] [Abstract][Full Text] [Related]
9. Accelerating the discovery of DGAT1 inhibitors through the application of parallel medicinal chemistry (PMC).
Yu Y; Wu Z; Shi ZC; He S; Lai Z; Cernak TA; Vachal P; Liu M; Liu J; Hong Q; Jian T; Guiadeen D; Krikorian A; Sperbeck DM; Verras A; Sonatore LM; Murphy BA; Wiltsie J; Chung CC; Gorski JN; Liu J; Xiao J; Wolff M; Tong SX; Madeira M; Karanam BV; Shen DM; Balkovec JM; De Vita RJ; Pinto S; Nargund RP
Bioorg Med Chem Lett; 2019 Jun; 29(11):1380-1385. PubMed ID: 30952592
[TBL] [Abstract][Full Text] [Related]
10. Benzimidazole-based DGAT1 inhibitors with a [3.1.0] bicyclohexane carboxylic acid moiety.
He S; Lai Z; Hong Q; Shang J; Reibarkh M; Kuethe JT; Liu J; Guiadeen D; Krikorian AD; Cernak TA; Dykstra KD; Sperbeck DM; Wu Z; Yu Y; Yang GX; Jian T; Verras A; Sonatore LM; Wiltsie J; Chung CC; Murphy BA; Gorski JN; Liu J; Xiao J; Wolff M; Tong SX; Madeira M; Karanam BV; Shen DM; Balkovec JM; Pinto S; Nargund RP; DeVita RJ
Bioorg Med Chem Lett; 2019 May; 29(10):1182-1186. PubMed ID: 30926247
[TBL] [Abstract][Full Text] [Related]
11. Discovery of pyrrolopyridazines as novel DGAT1 inhibitors.
Fox BM; Iio K; Li K; Choi R; Inaba T; Jackson S; Sagawa S; Shan B; Tanaka M; Yoshida A; Kayser F
Bioorg Med Chem Lett; 2010 Oct; 20(20):6030-3. PubMed ID: 20833038
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 6-phenylpyrimido[4,5-b][1,4]oxazines as potent and selective acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitors with in vivo efficacy in rodents.
Fox BM; Sugimoto K; Iio K; Yoshida A; Zhang JK; Li K; Hao X; Labelle M; Smith ML; Rubenstein SM; Ye G; McMinn D; Jackson S; Choi R; Shan B; Ma J; Miao S; Matsui T; Ogawa N; Suzuki M; Kobayashi A; Ozeki H; Okuma C; Ishii Y; Tomimoto D; Furakawa N; Tanaka M; Matsushita M; Takahashi M; Inaba T; Sagawa S; Kayser F
J Med Chem; 2014 Apr; 57(8):3464-83. PubMed ID: 24670009
[TBL] [Abstract][Full Text] [Related]
13. Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity model.
Yu T; Wu C; Shih N; Li Q; Chan C; Pan H; Yao D; Pan Y; Liang W; Shen L; Zhao H; Li J; Chen S
Bioorg Med Chem Lett; 2018 Jun; 28(10):1686-1692. PubMed ID: 29699923
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors.
Lee K; Goo JI; Jung HY; Kim M; Boovanahalli SK; Park HR; Kim MO; Kim DH; Lee HS; Choi Y
Bioorg Med Chem Lett; 2012 Dec; 22(24):7456-60. PubMed ID: 23141914
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a low-systemic-exposure DGAT-1 inhibitor with a picolinoylpyrrolidine-2-carboxylic acid moiety.
Yan J; Wang G; Dang X; Guo B; Chen W; Wang T; Zeng L; Wang H; Hu Y
Bioorg Med Chem; 2017 Sep; 25(17):4701-4714. PubMed ID: 28739155
[TBL] [Abstract][Full Text] [Related]
16. Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
Nakajima K; April M; Brewer JT; Daniels T; Forster CJ; Gilmore TA; Jain M; Kanter A; Kwak Y; Li J; McQuire L; Serrano-Wu MH; Streeper R; Szklennik P; Thompson J; Wang B
Bioorg Med Chem Lett; 2016 Feb; 26(4):1245-8. PubMed ID: 26804232
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel spirocyclic carboxylic acids as potent and orally bioavailable DGAT1 inhibitors and their biological evaluation.
Koul S; Kurhade S; Bhosale S; Naik K; Salunkhe V; Ravula S; Punde P; Velayutham R; Tiwari A; Ahl D; Malkapuram S; Mudagala V; Raje A; Umrani D; Tambe S; Patil P; Singh U; Bhuniya D; Hariharan N; Mookhtiar K
Bioorg Med Chem Lett; 2022 Apr; 62():128632. PubMed ID: 35189320
[TBL] [Abstract][Full Text] [Related]
18. Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.
Qian Y; Wertheimer SJ; Ahmad M; Cheung AW; Firooznia F; Hamilton MM; Hayden S; Li S; Marcopulos N; McDermott L; Tan J; Yun W; Guo L; Pamidimukkala A; Chen Y; Huang KS; Ramsey GB; Whittard T; Conde-Knape K; Taub R; Rondinone CM; Tilley J; Bolin D
J Med Chem; 2011 Apr; 54(7):2433-46. PubMed ID: 21413799
[TBL] [Abstract][Full Text] [Related]
19. Identification of 2-aminooxazole amides as acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) inhibitors through scaffold hopping strategy.
Kim HM; Smith MD; Kim JH; Caplen MA; Chan TY; McKittrick BA; Cook JA; van Heek M; Lachowicz J
Bioorg Med Chem Lett; 2013 Dec; 23(23):6410-4. PubMed ID: 24120540
[TBL] [Abstract][Full Text] [Related]
20. Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors.
Yun W; Ahmad M; Chen Y; Gillespie P; Conde-Knape K; Kazmer S; Li S; Qian Y; Taub R; Wertheimer SJ; Whittard T; Bolin D
Bioorg Med Chem Lett; 2011 Dec; 21(23):7205-9. PubMed ID: 22001092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
